These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11520139)
1. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139 [TBL] [Abstract][Full Text] [Related]
2. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126 [TBL] [Abstract][Full Text] [Related]
3. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567 [TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775 [TBL] [Abstract][Full Text] [Related]
5. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927 [TBL] [Abstract][Full Text] [Related]
6. Nuclear accumulation of beta-catenin protein in Wilms' tumours. Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228 [TBL] [Abstract][Full Text] [Related]
7. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921 [TBL] [Abstract][Full Text] [Related]
8. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Bian YS; Osterheld MC; Bosman FT; Fontolliet C; Benhattar J Am J Clin Pathol; 2000 Oct; 114(4):583-90. PubMed ID: 11026105 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Palacios J; Gamallo C Cancer Res; 1998 Apr; 58(7):1344-7. PubMed ID: 9537226 [TBL] [Abstract][Full Text] [Related]
11. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Garcia-Rostan G; Tallini G; Herrero A; D'Aquila TG; Carcangiu ML; Rimm DL Cancer Res; 1999 Apr; 59(8):1811-5. PubMed ID: 10213482 [TBL] [Abstract][Full Text] [Related]
13. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Wu R; Zhai Y; Fearon ER; Cho KR Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457 [TBL] [Abstract][Full Text] [Related]
14. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer. Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796 [TBL] [Abstract][Full Text] [Related]
15. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Tanyi J; Páy A; Rigó J; Nagy B; Papp Z Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313 [TBL] [Abstract][Full Text] [Related]
16. Beta-catenin mutation in carcinoma of the uterine endometrium. Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853 [TBL] [Abstract][Full Text] [Related]
17. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related]
18. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624 [TBL] [Abstract][Full Text] [Related]
19. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]